Canada's Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, particularly with respect to the life sciences priority
The development of a national pharmacare program, including the Canada Drug Agency, a national formulary and a rare diseases strategy
Policies or Program, Regulation
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
Regulation
Amendments to the Patented Medicines Regulations published in Canada Gazette, Part II on August 21, 2019 and June 10, 2020.